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Two in vitro assays of cell-mediated immunity, mixed leukocyte culture (MLC) and
cell-mediated lympholysis (CML) are frequently used as models of the afferent recogni-
tion and efferent destruction phases of allograft rejection, respectively (1, 2) . Together
these two tests serve as powerful tools in delineating the cellular and genetic elements
involved in histocompatibility and graft rejection (3, 4) .
Several studies have shown that cell-mediated immunity in the mouse may arise quite
early in development . For example, neonatal thymi of various mouse strains can induce a
graft-vs.-host reaction (GvHR) in vivo (5) or in vitro (6), while MLC and mitogen
responses can be demonstrated for thymus cells of embryonic mice (7) . Embryonic liver
and yolk sac cells, moreover, appear competent to initiate a GvHR even at the earliest
stages of development (day 12 and day 9 embryos, respectively) (8, 9) . For the spleen,
significant variation exists among different reports on the timing of onset of cell-
mediated immunocompetence (reference 10 ; and R . Auerbach and L . Kubai, unpublished
observations ; cf.5) . At one extreme, Adler et al . (10) reported that spleen cells from
C57BL/6 mice less than 2-3 wk of age fail to respond to allogeneic stimulation in one-way
MLC, while at the same time Auerbach and Kubai (unpublished observation) found that
1-day old spleen cells, also from C57BL/6 animals, could initiate a GvHR in vitro .
The present report deals with the ontogeny of the spleen as measured by the
ability of spleen cells to respond in one-way MLC and their ability to lyse both
specific and third-party (partially cross-reactive) target cells in CML .
Materials and Methods
For ontogeny studies male and female mice from newborn to 1 mo of age were used ; in
experiments involving older animals only male mice were employed. C57BL/10J (B10), B10.D2,
and B10.BR were obtained primarily from Jackson Laboratories, Bar Harbor, Maine although
some animals from our own colony were used .
MLCtests were carried outusing themicromethod ofAlter et al . (4) . The cultures contained 1 x
10 6 responding and 1 x 10 6 X-irradiated (190 R/min for 10 min) stimulating cells in a total of 0.2 ml
RPMI 1640 medium containing 5% heat-inactivated human plasma . Cultures were labeled with
tritiated thymidine (2 WCi/well) for 12 h after 90-92 h of incubation, with assays carried outon five
replicate cultures .
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To generate cytotoxic effector cells, 25-70 x 106 responding cells were mixed with a similar
number of X-irradiated cells for 4-5 days. Phytohemagglutinin (PHA)-stimulated lymph node
cells were labeled with radioactive sodium chromate ("Cr) and used as target cells in CML with
100 effector cells per target cell. The percent CML was calculated as previously reported (4).
Assays were carried out on triplicate cultures. Experiments for different aged responding mice
were done at different times, but each experiment was repeated two to three times with similar
results. Formice beyond 16 days of age, effector cells were harvested after 96 hof MLCincubation
and then mixed with target cells for 3 h; for animals of 16 days and younger, initial incubation
time was115-120 hand theCMLassaytime was 4.5 hto obtain the strongest possible response.
The stimulation ratio (SR) was calculated as the ratio of counts per minute in the allogeneic
mixture to counts per minute in the syngeneiccontrol mixture. t tests were performed on the log
convertedcounts per minute ofthe allogeneic mixturecompared with thelogcounts perminute in
the isogeneiccontrol mixture, with the significance of stimulation then expressed as aP value.
Results and Discussion
The experiments (Table I) show that spleen cells from neonatal B10 mice are
capable ofresponding to allogeneic stimulation in MLC . While there is a general
trend toward higher stimulation ratios in MLC with increasing age it is impor-
tant to note that significant MLC reactivity is present as soon as the mouse is
born (day 0). In contrast, CML activity as measured by killing of specific target
cells (B10.D2) was not seen until day 7. Moreover, the cross-killing which is seen
on third-party cells from B10.BR mice after sensitization with B10.D2 is not
significant until day 27 . Thus in the ontogeny of these reactions, spleen cells
respond by proliferation in MLC before they are able to mediate CML, and even
after CML potential is developed against specific target cells there is an interval
in development where such specific killing activity is distinct from the cross-
killing capacity towards third-party target.
The dichotomy of MLC and CML ontogeny in spleen cells is not likely to be
due simply to the fact that the ratio between responding and stimulating cells is
not optimal since varying the responder-to-stimulator ratios from 1 :2 to 8 :1 still
does not result in significant CML by spleen cells from 4- and 5-day old B10 mice
(data not shown) . One possible interpretation of the early MLC response is that
a "back reaction" is taking place, i .e., that adult X-irradiated B10.D2 stimulator
cells respond to the antigen(s) on the B10 responding cells and release a factor
which then stimulates the B10 cells to divide. That this is probably not the case
is demonstrated by results ofexperiments not part of the present series in which
2-day old B10 spleen cells were stimulated with X-irradiated BDF, spleen cells
derived from adult thymectomized, lethally irradiated, bone marrow-reconsti-
tuted animals ; positive MLC responses were still obtained.
Since results from a number ofstudies (11-13) suggest that an MLC-prolifera-
tive response is a prerequisite for or at least highly helpful to the development of
CML it is important to rule out as best as possible that the ontogenetic sequence
described in our study is not simply a reflection of a gradual increase in the
magnitude of the MLC-proliferatioe response . The data shown in Table I seem to
argue against such an interpretation. First, with respect to the apparently
delayed onset of a specific CML response compared with MLC proliferation, cells
of mice either 13 or 16 days old show no greater MLC response as revealed by
stimulation ratios than do cells of mice which are 4 or 5 days old. Yet in the older
mice excellent CML occurs (13.6 and 40.9%), while in the younger animals noWU ET AL.
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TABLE I
Ontogenesis ofMLC and Lympholytic Responses (CML) ofB10 Spleen Cells to B10.D2 Spleen
Cells
' See Materials and Methods for legends.
CML is seen (-13.3 and -9.6%) . With respect to cross-reactivity ofkilling, while
16- and 27-day old mice show essentially the same degree of specific killing of
1310 .D2 cells (about 40%) the 16-day group gives no cross-killing at all while the
27-day group shows significant destruction of B10.BR cells.
We should emphasize that whereas the above findings are true for splenic
lymphocytes, we have not yet described the ontogenic pattern for other organs
such as the thymus, liver, or yolk sac. The pattern of development of immuno-
competence is complex (cf. 5) and both differential maturation and selective
migration of lymphoid cells may influence the appearance of functional cells in
specific organs during development.
Several reports (2, 14-19) suggest heterogeneity of thymus-derived lympho-
cytes (T cells) . For example, different subpopulations of T cells have been
demonstrated by synergism studies in GvHR, one as effector cells and the other
as amplifier cells (14). Later this was confirmed in MLC and CML reactions (15),
also by demonstration of synergism between populations from different lym-
phatic organs. Different subpopulations of T cells have also been implicated for
GvHR and helper function in antibody responses (16), for inhibition of macro-
phage migration and CML reaction (17), for responses to PHA andconcanavalin
A mitogens (18), and for GvHR and CML reactions (19). The cell adsorption
method (2) to remove cytotoxic T cells provided perhaps the most direct indica-
tion for, although it did notprove, subpopulations reactive in MLC proliferation
and CML cytotoxicity, correlating with genetic studies (3) which have shown a
dichotomy for the genes controlling MLC and CML reactions.
The results presented in this paper demonstrate that in the spleen three
phenomena associated with the development of CML arise at different times:
proliferation induced by allogeneic stimulation, specific killing of target cells
used for sensitization, and cross-killing of third-party target cells. These find-
ings may be of particular significance in terms of the establishment of specific
immunological unresponsiveness (tolerance) during embryogenesis (20), since
Age of
re-
MLC (mean cpm - SD) % CML (mean ± SD)
sponder Syngeneic MLC Allogeneic MLC
SR P B10 target B10.BR target Bl0.D2 target
cells (1310 + 1310x) (1110 + B10.D2x)
days
0 10,698 - 997 18,988 - 1,604 1.77 <0.0005 - - -
1 10,744 - 1,947 24,722 - 2,175 2.30 <0.0005 - - -
4 5,626 - 615 12,077 - 786 2.14 <0.0005 -19.8 - 3.1 -13.8 ~ 4.5 -13.3 - 4.8
5 10,210 - 787 13,263 - 1,035 1.29 <0.005 -19.4 - 3.4 -11.0 - 4.7 -9.6 - 4.5
7 43,116 '_ 5,950 69,726 - 5,579 1.61 1 <0.0005 -7.8 - 4.3 -7.4 - 2.5 14.6 - 8.0
13 6,940 - 623 11,862 - 1,457 1.61 <0.0005 -25.7 - 10.2 -2.3 - 1 .1 13.6 - 2.8
16 8,684 - 1,095 15,066 - 1,531 1.73 <0.0005 -4.5 - 4.6 -7.2 - 2.4 40.9 - 13.4
22 18,994 - 3,982 54,750 - 6,658 2.88 <0.0005 -3.9 - 2.3 3.0 - 0.8 24.4 - 0.8
27 25,341 - 6,227 89,522 - 13,329 3.53 <0.0005 -3.5 - 3.4 11.2 - 1 .7 40.4 - 3.2
46 17,913 - 1,973 76,957 - 9,666 ! 4.29 ~, <0.0005 -24.0 - 6.8 7.4 - 11.0 60.5 - 2.8
59 73,123 ± 8,120 179496 10,000 2.45 <0.0005
1
-0.2 --t 0.8 7.8 --t 1 .4 36.1 - 2.6
88 19,027 - 2,618 81
,
,257 - 7,987 4.28 <0.0005 -4.0 - 2.4 7.7 - 3.0 39.8 - 5.3
320 17,962 - 3,736 84,097 - 10,456 4.68 <0.0005 -3.0 - 2.2 12.6 - 2.0 76.2 - 10.41304
￿
WU ET AL.
￿
BRIEF DEFINITIVE REPORT
differential maturation of T-cell subfunctions could serve to alter the equilib-
rium between suppressor cells, cells serving as stimulators of antireceptor or
blocking antibodies, cells essential for the generation of specific memory, etc.
Similarly, the differential ontogeny of T-cell subfunctions' may provide the
biological basis for the transient successful survival, then immunological de-
struction of potentially autoimmune or graft-vs.-host-reactive maternal lymph-
oid cells known to be present during fetal and neonatal periods of mouse
development (21). Finally, the possibility that in the ontogeney of immune
responses there is a gradual acquisition of the ability to cross-kill is an intrigu-
ing finding which may well relate to somatic development of specificity of
recognition by T cells.
Summary
While spleen cells from neonatal B10 (H-2°) are reactive (proliferate) in one-
way mixed leukocyte culture, cell-mediated lympholysis reactivity does not
arise until 7 days of age. When B10 cells are sensitized to B10 .D2 (H-2 d), cross-
killing of third-party B10.BR (H-2') target is always lower than the specific
killing of B10.D2 targets and is not demonstrable until 27 days after birth.
Received for publication 23 June 1975 .
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